Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1619 1638 1654 3783 3786
This examiner grants 19% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17911626 | DEFORMABLE HYDROGEL PARTICLES AND PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT COMPRISING SAME | Final Rejection | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 18540458 | Synthesis of Thiophene Derivatized Polyphenolic Calixarenes | Non-Final OA | University of Cincinnati |
| 18543657 | COMPOSITIONS CONTAINING ACTIVE AGENT AND UV PROTECTION PROPERTIES | Non-Final OA | L'OREAL |
| 17879926 | THERAPEUTIC PATCH FOR GASTROINTESTINAL TRACT AND METHOD OF MANUFACTURING SAME | Final Rejection | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY |
| 18933195 | FORMULATIONS AND DOSES OF PEGYLATED URICASE | Final Rejection | Cartesian Therapeutics, Inc. |
| 17759592 | Droplet Formation and Particle Morphology | Final Rejection | Elektrofi, Inc. |
| 18284886 | AGENTS FOR DYEING KERATINOUS MATERIAL, IN PARTICULAR HUMAN HAIR, CONTAINING AMINOSILICONES, PIGMENTS AND PARTICULAR ALKYLENE GLYCOLS | Non-Final OA | HENKEL AG & CO. KGAA |
| 18708238 | A PERSONAL CLEANSING COMPOSITION | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 17507951 | BACTERICIDAL COATING COMPOSITIONS AND METHODS USING SAME | Non-Final OA | Rowan University |
| 17939524 | COMPOSITE HYDROGEL FOR LIGHT-CURED 3D CELL-LADEN PRINTING AND PREPARATION METHOD AND APPLICATION THEREOF | Non-Final OA | SHANDONG UNIVERSITY |
| 16722249 | METHOD OF TREATING NONALCOHOLIC STEATOHEPATITIS | Final Rejection | Vector Vitale IP LLC |
| 18506664 | METHOD OF FORMING PEPTIDE-COATED NANOPARTICLES | Non-Final OA | Icahn School of Medicine at Mount Sinai |
| 18706770 | COSMETIC | Non-Final OA | SHISEIDO COMPANY, LTD. |
| 18564588 | MRNA DELIVERY USING LIPID NANOPARTICLES | Non-Final OA | THE UNIVERSITY OF BRITISH COLUMBIA |
| 18576406 | CATIONIC GLUCAN ESTER DERIVATIVES | Non-Final OA | NUTRITION & BIOSCIENCES USA 4, INC. |
| 18161857 | METHODS FOR PREPARING PARTICLES AND RELATED COMPOSITIONS | Final Rejection | ModernaTX, INC. |
| 18170602 | COMPOSITION FOR SUSTAINED-RELEASE INJECTION COMPRISING DESLORELIN | Non-Final OA | INVENTAGE LAB INC. |
| 18534290 | METHODS OF PREPARING STABLE NUCLEIC ACID LIQUID FORMULATIONS | Non-Final OA | University of North Carolina at Wilmington |
| 18556818 | Pharmaceutical Composition For Treating Hyperlipidemia And Preparation Method Therefor | Non-Final OA | SICHUAN JIUZHANG BIOLOGICAL SCIENCE AND TECHNOLOGY CO., LTD. |
| 17935022 | NANOPARTICLE PHARMACEUTICAL COMPOSITIONS WITH REDUCED NANOPARTICLE SIZE AND IMPROVED POLYDISPERSITY INDEX | Final Rejection | Sirnaomics, Inc. |
| 18553986 | IN VIVO ORAL INSULIN DELIVERY VIA COVALENT ORGANIC FRAMEWORKS | Non-Final OA | New York University in Abu Dhabi Corporation |
| 18223944 | OCULAR COMPOSITIONS | Non-Final OA | Re-Vana Therapeutics Ltd. |
| 18005114 | Polypeptide Polymer-Doped Bone Marrow Cavity Filler and Use Thereof in Treatment of Osteomyelitis | Non-Final OA | SHANGHAI FIRST PEOPLE'S HOSPITAL |
| 17920317 | Transfection and Transduction System | Final Rejection | N4 Pharma UK Limited |
| 17915251 | CANCER THERAPY WITH MICROBUBBLES | Final Rejection | SONOTARG LIMITED |
| 17913978 | WHOLE-CELL CONSTITUENT TRANSPORT SYSTEM AND APPLICATION THEREOF | Final Rejection | SUZHOU ERSHENG BIOPHARMACEUTICAL CO., LTD. |
| 17783022 | GOLDEN LIPID NANOPARTICLES FOR GENE THERAPY | Final Rejection | UNIVERSIDAD DEL PAÍS VASCO/EUSKAL HERRIKO UNIBERTSITATEA |
| 17755823 | COMPOSITIONS CONTAINING METALLIC COMPOUNDS FOR PROLONGED DISINFECTION OF SURFACES AND THEIR USES | Final Rejection | NANOMATERIALES QUIMICOS AVANZADOS, S.A. DE C.V. |
| 17500392 | Microrobot and Method of Manufacturing the Microrobot | Non-Final OA | MIRACURE Co., Ltd |
| 16953167 | METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION | Final Rejection | Abraxis BioScience, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy